Researchers at the College of Agriculture (ESIT) of the National Institute of Polytechnic (IPN), Mexico, are developing fabrics and garments that would also have health benefits. Soon, there would be a day when clothing would not only ...
Tags: Textiles, Health Benefits
Pharmaceutical grade containers distributor Kush Bottles has announced the opening of a new warehouse, sales and distribution center for its child-resistant prescription medicine containers, in Seattle, US. Medical facilities, pharmacies ...
Canadian manufacturer of over-the-counter (OTC) pharma products Vita Health has announced the recall of three lots of its Compliments Iron Ferrous Gluconate tablets in consultation with Health Canada, over labeling issue. At least one ...
Tags: OTC Tablets, Labeling Issue
One in four surgical errors are caused due to technology or equipment issues, and checks on medical devices before undertaking a surgery could reduce these problems, according to a new study. Surgeries that usually rely on use of ...
Tags: Medical Device, Medicine
PPG Industries has reached an agreement to sell 51% interest in Transitions Optical to Essilor International for $1.73bn. This deal has an enterprise value of approximately $3.4bn, of which PPG will receive cash of $1.73bn before tax or ...
Tags: PPG Industries, Medicine
Researchers at A*STAR’s Genome Institute of Singapore (GIS) have identified potential targets for therapeutic drugs against aggressive breast cancer. Working in collaboration with local and international institutions, GIS scientists ...
Tags: therapeutic drugs, Medicine
Daiichi Sankyo Company has decided to expand its collaborative drug discovery program with universities and research institutions based in Japan, Take a New challenge for Drug diScovery (TaNeDS) Global Program, to Germany, Switzerland and ...
Tags: Daiichi Sankyo, Medicine
Global healthcare products provider Perrigo Company and Elan have entered into a definitive agreement, under which the latter will be acquired by a new holding company in Ireland, New Perrigo, in a $8.6bn cash and stock transaction. ...
British drug-maker GlaxoSmithKline (GSK) has reached settlement with the attorneys general of eight US states over misleading marketing of the diabetes treatment drug, Avandia, and even agreed to pay $229m to settle the lawsuits. Without ...
Tags: Avandia Lawsuits, Medicine
Imprimis Pharmaceuticals has received approval from the Institutional Review Board (IRB) to initiate Phase III clinical trial protocol of its new topical non-steroidal anti-inflammatory drug (NSAID) candidate, Impracor. Impracor is based ...
Pharmadiet, the Spain subsidiary of OPKO Health, has obtained Spanish approval for commercialization of its oral and injectable formulations of citicoline, developed to enhance phosphatidylcholine levels in the brain. Agencia Espa ola de ...
Specialty pharmaceutical company Avion Pharmaceuticals has launched a prescription prenatal supplement with B vitamins and Ginger, Prenate AM, to ease pregnancy symptoms like nausea and vomiting in pregnancy (NVP). Avion CEO Mark Pugh ...
Tags: Prenatal Supplement, Medicine
Ireland-based biotechnology company Elan has reported a net income of $2.29bn, or $4.28 per share, for the second quarter ended on 30 June 2013 compared to a net loss of $28.5m, or $0.05per share in 2012. Operating loss for the second ...
Eli Lilly and Company has reported 31% increase in net income to $1.21bn, or $1.11 per diluted share, for the second quarter ended on 30 July 2013, compared to $923.6m, or $0.83, for the same period last year. Increase in net income and ...
GlaxoSmithKline (GSK) has announced Health Canada approval of a BRAF-inhibitor, Tafinlar, and a first in class MEK-inhibitor, Mekinist, for melanoma patients with BRAF V600 mutation. Both, Tafinlar (dabrafenib mesylate) and Mekinist ...
Tags: Melanoma Drugs, Medicine